Importantly, analysis of GR expression in cohorts of patients with colorectal adenocarcinoma, superficial bladder cancer, ovarian serous cystadenocarcinoma and squamous cell lung carcinoma also revealed that increased GR expression was associated with poor prognosis (Supplementary Fig. 2). Here, NR3C1 is linked to ovarian serous cystadenocarcinoma.